nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—osteoarthritis	0.937	1	CbGaD
Nepafenac—PTGS2—skeletal joint—osteoarthritis	0.00593	0.243	CbGeAlD
Nepafenac—PTGS2—leg—osteoarthritis	0.00453	0.186	CbGeAlD
Nepafenac—PTGS2—synovial membrane of synovial joint—osteoarthritis	0.0045	0.185	CbGeAlD
Nepafenac—PTGS2—hindlimb—osteoarthritis	0.00405	0.166	CbGeAlD
Nepafenac—PTGS2—cartilage tissue—osteoarthritis	0.00399	0.163	CbGeAlD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00391	0.13	CbGpPWpGaD
Nepafenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.0031	0.103	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00254	0.0845	CbGpPWpGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00201	0.0671	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00141	0.047	CbGpPWpGaD
Nepafenac—Diclofenac—CXCL8—osteoarthritis	0.00122	0.137	CrCbGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00112	0.0373	CbGpPWpGaD
Nepafenac—Ketoprofen—CXCL8—osteoarthritis	0.00108	0.121	CrCbGaD
Nepafenac—Ketorolac—PTGS2—osteoarthritis	0.001	0.112	CrCbGaD
Nepafenac—Bromfenac—PTGS2—osteoarthritis	0.000963	0.108	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—CRP—osteoarthritis	0.000895	0.0298	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—FN1—osteoarthritis	0.000826	0.0275	CbGpPWpGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.000825	0.0274	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS2—osteoarthritis	0.000819	0.0915	CrCbGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.000766	0.0255	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS2—osteoarthritis	0.000761	0.0851	CrCbGaD
Nepafenac—Fenbufen—PTGS2—osteoarthritis	0.000745	0.0833	CrCbGaD
Nepafenac—PTGS1—tendon—osteoarthritis	0.000713	0.0292	CbGeAlD
Nepafenac—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	0.000711	0.0236	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	0.000691	0.023	CbGpPWpGaD
Nepafenac—PTGS2—tendon—osteoarthritis	0.000681	0.0279	CbGeAlD
Nepafenac—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	0.000656	0.0218	CbGpPWpGaD
Nepafenac—Salsalate—PTGS2—osteoarthritis	0.000647	0.0723	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—osteoarthritis	0.0006	0.02	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000582	0.0194	CbGpPWpGaD
Nepafenac—Fenoprofen—PTGS2—osteoarthritis	0.000535	0.0598	CrCbGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.000507	0.0169	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.000498	0.0166	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS2—osteoarthritis	0.000496	0.0554	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000462	0.0154	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.000417	0.0139	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.000407	0.0136	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—TNF—osteoarthritis	0.000405	0.0135	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTO1—osteoarthritis	0.00037	0.0123	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	0.000366	0.0122	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—osteoarthritis	0.000356	0.0398	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000327	0.0109	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.000327	0.0109	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	0.000322	0.0107	CbGpPWpGaD
Nepafenac—Ketoprofen—PTGS2—osteoarthritis	0.000316	0.0353	CrCbGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000277	0.00921	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.000263	0.00874	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.00026	0.00864	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.000213	0.00709	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000208	0.00694	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000202	0.00671	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000197	0.00656	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000176	0.00586	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000164	0.00545	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.000161	0.00537	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00016	0.00533	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000159	0.00528	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.000148	0.00494	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	0.00013	0.00433	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	0.000119	0.00396	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FMOD—osteoarthritis	0.00011	0.00367	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	0.000107	0.00357	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000105	0.00349	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FMOD—osteoarthritis	0.000104	0.00348	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	0.000103	0.00342	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	9.7e-05	0.00323	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	9.59e-05	0.00319	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	9.44e-05	0.00314	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IHH—osteoarthritis	9.31e-05	0.0031	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	9.07e-05	0.00302	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGES—osteoarthritis	8.98e-05	0.00299	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FMOD—osteoarthritis	8.75e-05	0.00291	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	7.99e-05	0.00266	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	7.62e-05	0.00253	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	7.46e-05	0.00248	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTGES—osteoarthritis	7.13e-05	0.00237	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFBI—osteoarthritis	6.94e-05	0.00231	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTO1—osteoarthritis	6.33e-05	0.00211	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BGN—osteoarthritis	6.13e-05	0.00204	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	6.02e-05	0.002	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GSTO1—osteoarthritis	6e-05	0.002	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BGN—osteoarthritis	5.81e-05	0.00193	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	5.44e-05	0.00181	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	5.08e-05	0.00169	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTO1—osteoarthritis	5.02e-05	0.00167	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BGN—osteoarthritis	4.86e-05	0.00162	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	3.96e-05	0.00132	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SMAD3—osteoarthritis	2.85e-05	0.000949	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—osteoarthritis	1.76e-05	0.000586	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—osteoarthritis	1.21e-05	0.000402	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—osteoarthritis	9.1e-06	0.000303	CbGpPWpGaD
